Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

BACKGROUND: Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide trea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Metab J
Hlavní autoři: Park, Sejeong, Park, So Young, Kim, Yu Jin, Hong, Soo Min, Chon, Suk, Oh, Seungjoon, Woo, Jeong-taek, Kim, Sung-Woon, Kim, Young Seol, Rhee, Sang Youl
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Diabetes Association 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929228/
https://ncbi.nlm.nih.gov/pubmed/27098506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2016.40.3.240
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky